Skip to main content
SpringerLink
Log in

Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial

  • Chapter
  • First Online:
Natural Products and Human Diseases

Part of the book series: Advances in Experimental Medicine and Biology ((PMISB,volume 1328))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hong S. N. (2018). Genetic and epigenetic alterations of colorectal cancer. Intestinal Research, 16(3), 327–337. 

    Google Scholar 

  2. Arnold, M., Sierra, M. S., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2017). Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66(4), 683–691.

    Article  Google Scholar 

  3. Fakheri, H., Janbabai, G., Bari, Z., & Eshqi, F. (2008). The epidemiologic and clinical-pathologic characteristics of colorectal cancers from 1999 to 2007 in Sari, Iran. Journal of Mazandaran University of Medical Sciences, 18(67), 58–66.

    Google Scholar 

  4. Nikbakht, H., Aminisani, N., AsghariJafarabadi, M., et al. (2015). Trends in the Incidence of Colorectal Cancer and Epidemiologic and Clinical Characteristics of Survivors in Babol City in 2007–2012. Journal of Babol University of Medical Sciences, 17(1), 7–14.

    Google Scholar 

  5. Nicholson, F. B., Barro, J. L., Atkin, W., Lilford, R., Patnick, J., Williams, C. B., et al. (2005). Review article: Population screening for colorectal cancer. Alimentary Pharmacology & Therapeutics, 22(11–12), 1069–1077.

    Article  CAS  Google Scholar 

  6. Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., et al. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. New England Journal of Medicine, 328(19), 1365–1371.

    Article  CAS  Google Scholar 

  7. Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., et al. (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: A multicentre randomised controlled trial. Lancet, 375(9726), 1624–1633.

    Article  Google Scholar 

  8. Blanchard, C. M., Stein, K. D., Baker, F., Dent, M. F., Denniston, M. M., Courneya, K. S., et al. (2004). Association between current lifestyle behaviors and health-related quality of life in breast, colorectal, and prostate cancer survivors. Psychology & Health, 19(1), 1–13.

    Article  Google Scholar 

  9. Blanchard, C. M., Courneya, K. S., Stein, K., & American Cancer Society’s SCS-II. (2008). Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: Results from the American Cancer Society’s SCS-II. Journal of Clinical Oncology, 26(13), 2198–2204.

    Article  Google Scholar 

  10. Taylor, K. L., Shelby, R., Gelmann, E., & McGuire, C. (2004). Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Journal of the National Cancer Institute, 96(14), 1083–1094.

    Article  Google Scholar 

  11. Taupin, D., Chambers, S. L., Corbett, M., & Shadbolt, B. (2006). Colonoscopic screening for colorectal cancer improves quality of life measures: A population-based screening study. Health and Quality of Life Outcomes, 4(1), 82. https://doi.org/10.1186/1477-7525-4-82.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Giovannucci, E., Ascherio, A., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1995). Physical activity, obesity, and risk for colon cancer and adenoma in men. Annals of Internal Medicine, 122(5), 327–w34.

    Article  CAS  Google Scholar 

  13. Miller, E. A., Keku, T. O., Satia, J. A., Martin, C. F., Galanko, J. A., & Sandler, R. S. (2007). Calcium, dietary, and lifestyle factors in the prevention of colorectal adenomas. Cancer, 109(3), 510–517.

    Article  CAS  Google Scholar 

  14. Chan, D. S., Lau, R., Aune, D., Vieira, R., Greenwood, D. C., Kampman, E., & Norat, T. (2011). Red and processed meat and colorectal cancer incidence: Meta-analysis of prospective studies. PLoS One, 6(6), e20456. https://doi.org/10.1371/journal.pone.0020456.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001). The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut, 48(4), 526–535.

    Article  CAS  Google Scholar 

  16. Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., et al. (2003). A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. New England Journal of Medicine, 348(10), 883–890.

    Article  CAS  Google Scholar 

  17. Binefa, G., Rodríguez-Moranta, F., Teule, À., & Medina-Hayas, M. (2014). Colorectal cancer: From prevention to personalized medicine. World Journal of Gastroenterology, 20(22), 6786–6808.

    Article  Google Scholar 

  18. Ismail, N. I., Othman, I., Abas, F., Lajis, N. H., & Naidu, R. (2019). Mechanism of apoptosis induced by curcumin in colorectal cancer. International Journal of Molecular Sciences, 20(10), pii: E2454. https://doi.org/10.3390/ijms20102454.

    Article  CAS  Google Scholar 

  19. Epstein, J., Sanderson, I. R., & MacDonald, T. T. (2010). Curcumin as a therapeutic agent: The evidence from in vitro, animal and human studies. The British Journal of Nutrition, 103(11), 1545–1557.

    Article  CAS  Google Scholar 

  20. Panahi, Y., Ahmadi, Y., Teymouri, M., Johnston, T. P., Sahebkar, A. (2018). Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. Journal of Cellular Physiology, 233(1), 141–152.

    Google Scholar 

  21. Shehzad, A., & Lee, Y. (2010). Curcumin: Multiple molecular targets mediate multiple pharmacological actions: A review. Drugs of the Future, 35(2), 113. https://doi.org/10.1358/dof.2010.035.02.1426640.

    Article  CAS  Google Scholar 

  22. Panahi, Y., Khalili, N., Sahebi, E., Namazi, S., Simental-Mendía, L.E., Majeed, M., Sahebkar, A. (2018) Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes Mellitus: a randomized double-blind placebo-controlled trial. Drug Research, 68(7), 403–409. 

    Google Scholar 

  23. Teymouri, M., Pirro, M., Johnston, T. P., Sahebkar, A. (2017). Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. BioFactors, 43(3), 331–346.

    Google Scholar 

  24. Iranshahi, M., Sahebkar, A., Takasaki, M., Konoshima, T., & Tokuda, H. (2009). Cancer chemopreventive activity of the prenylatedcoumarin, umbelliprenin, in vivo. European Journal of Cancer Prevention, 18(5), 412–415.

    Article  CAS  Google Scholar 

  25. Momtazi, A. A., Derosa, G., Maffioli, P., Banach, M., & Sahebkar, A. (2016). Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases. Molecular Diagnosis & Therapy, 20(4), 335–345.

    Article  CAS  Google Scholar 

  26. Shehzad, A., Lee, J., & Lee, Y. S. (2013). Curcumin in various cancers. Biofactors, 39, 56–68.

    Article  CAS  Google Scholar 

  27. Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011). Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular Cancer, 10(1), 12–19.

    Article  CAS  Google Scholar 

  28. Abdollahi, E., Momtazi, A. A., Johnston, T. P., & Sahebkar, A. (2018). Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? Journal of Cellular Physiology, 233(2), 830–848.

    Article  CAS  Google Scholar 

  29. Ghandadi, M., Sahebkar, A. (2017) Curcumin: An effective inhibitor of interleukin-6. Current Pharmaceutical Design, 23(6), 921–931.

    Google Scholar 

  30. Mollazadeh, H., Cicero, A. F. G., Blesso, C. N., Pirro, M., Majeed, M., & Sahebkar, A. (2019). Immune modulation by curcumin: The role of interleukin-10. Critical Reviews in Food Science and Nutrition, 59(1), 89–101.

    Article  CAS  Google Scholar 

  31. FitzGerald, S. P., Lamont, J. V., McConnell, R. I., & Benchikh, E. O. (2005). Development of a high-throughput automated analyzer using biochip array technology. Clinical Chemistry, 51(7), 1165–1176.

    Article  CAS  Google Scholar 

  32. Molloy, R. M., Mc Connell, R. I., Lamont, J. V., & FitzGerald, S. P. (2005). Automation of biochip array technology for quality results. Clinical Chemistry and Laboratory Medicine, 43(12), 1303–1313.

    Article  CAS  Google Scholar 

  33. Proskorovsky, I., Lewis, P., Williams, C. D., Jordan, K., Kyriakou, C., Ishak, J., et al. (2014). Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. Health and Quality of Life Outcomes, 12, 35. https://doi.org/10.1186/1477-7525-12-35.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Derogar, M., van der Schaaf, M., & Lagergren, P. (2012). Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population. Acta Oncologica, 51(1), 10–16.

    Article  Google Scholar 

  35. Mystakidou, K., Tsilika, E., Parpa, E., Kalaidopoulou, O., Smyrniotis, V., & Vlahos, L. (2001). The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: Validity and reliability in a Hellenic sample. International Journal of Cancer, 94(1), 135–139.

    Article  Google Scholar 

  36. Panahi, Y., Ghanei, M., Bashiri, S., Hajihashemi, A., & Sahebkar, A. (2015). Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial. Drug Research, 65(11), 567–573.

    CAS  PubMed  Google Scholar 

  37. Panahi, Y., Sahebkar, A., Parvin, S., & Saadat, A. (2012). A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Annals of Clinical Biochemistry, 49(Pt 6), 580–588.

    Article  CAS  Google Scholar 

  38. Sahebkar, A. (2014). Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytotherapy Research, 28(5), 633–642.

    Article  CAS  Google Scholar 

  39. Sahebkar, A., Cicero, A. F., Simental-Mendia, L. E., Aggarwal, B. B., & Gupta, S. C. (2016). Curcumin downregulates human tumor necrosis factor-alpha levels: A systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 107, 234–242.

    Article  CAS  Google Scholar 

  40. Panahi, Y., Saadat, A., Beiraghdar, F., & Sahebkar, A. (2014). Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: A randomized double-blind placebo-controlled trial. Phytotherapy Research, 28(10), 1461–1467.

    Article  CAS  Google Scholar 

  41. Howells, L. M., Iwuji, C. O. O., Irving, G. R. B., Barber, S., Walter, H., Sidat, Z., et al. (2019). Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial. The Journal of Nutrition, 149(7), 1133–1139.

    Article  Google Scholar 

  42. Schneider, A., Hossain, I., VanderMolen, J., & Nicol, K. (2017). Comparison of remicade to curcumin for the treatment of Crohn’s disease: A systematic review. Complementary Therapies in Medicine, 33, 32–38.

    Article  Google Scholar 

  43. Sharma, C., Kaur, J., Shishodia, S., Aggarwal, B. B., & Ralhan, R. (2006). Curcumin down regulates smokeless tobacco-induced NF-κB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology, 228(1), 1–5.

    Article  CAS  Google Scholar 

  44. Jeong, W. S., Kim, I. W., Hu, R., & Kong, A. N. (2004). Modulatory properties of various natural chemopreventive agents on the activation of NF-κB signaling pathway. Pharmaceutical Research, 21(4), 661–670.

    Article  CAS  Google Scholar 

  45. He, Z. Y., Shi, C. B., Wen, H., Li, F. L., Wang, B. L., & Wang, J. (2011). Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Investigation, 29(3), 208–213.

    Article  CAS  Google Scholar 

  46. Yin, J., Wang, L., Wang, Y., Shen, H., Wang, X., & Wu, L. (2019). Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-β/Smad2/3 signaling pathway. Oncotargets and Therapy, 12, 3893–3903.

    Article  CAS  Google Scholar 

  47. Sharma, R. A., McLelland, H. R., Hill, K. A., Ireson, C. R., Euden, S. A., Manson, M. M., et al. (2001). Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clinical Cancer Research, 7(7), 1894–1900.

    CAS  PubMed  Google Scholar 

Download references

Conflict of Interest

Muhammed Majeed is the founder of Sabinsa Corp. and Sami Labs Ltd. Other authors declare no competing interests.

Funding

This study was financially supported by the Research Council at the Mashhad University of Medical Sciences (Mashhad, Iran).

Author information

Authors and Affiliations

  1. Pharmacotherapy Department, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran

    Yunes Panahi

  2. Student Research Committee, Iranian UNESCO Center of Excellence for Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran

    Maryam Saberi-Karimian

  3. School of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

    Omid Valizadeh

  4. Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran

    Behzad Behnam

  5. Pharmaceutics Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

    Behzad Behnam

  6. Department of Internal Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran

    Alireza Saadat

  7. Department of Food Science and Technology, Quchan Branch, Islamic Azad University, Quchan, Iran

    Tannaz Jamialahmadi

  8. Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    Tannaz Jamialahmadi

  9. Sabinsa Corporation, East Windsor, NJ, USA

    Muhammed Majeed

  10. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

    Amirhosein Sahebkar

  11. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    Amirhosein Sahebkar

  12. School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

    Amirhosein Sahebkar

Authors
  1. Yunes Panahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryam Saberi-Karimian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Omid Valizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Behzad Behnam
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alireza Saadat
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tannaz Jamialahmadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Muhammed Majeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Amirhosein Sahebkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Behzad Behnam or Amirhosein Sahebkar .

Editor information

Editors and Affiliations

  1. Pharmacy, Medical Biotechnology, Mashhad University of Medical Sciences, Mashhad, Iran

    Amirhossein Sahebkar

  2. Diabetes, Endocrinology & Metabolism, The University of Hull, Brough, UK

    Thozhukat Sathyapalan

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Panahi, Y. et al. (2021). Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial. In: Sahebkar, A., Sathyapalan, T. (eds) Natural Products and Human Diseases. Advances in Experimental Medicine and Biology(), vol 1328. Springer, Cham. https://doi.org/10.1007/978-3-030-73234-9_1

Download citation

Publish with us

Policies and ethics

Search

Navigation